Rb Capital Management, LLC Gilead Sciences, Inc. Transaction History

Rb Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $165,879 - $216,460	-2,740 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $13,329 - $14,758	-187 Reduced 6.39%	2,740 $212,000
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $4,606 - $5,373	-71 Reduced 2.37%	2,927 $207,000
Q1 2018 Apr 19, 2018	BUY	$72.84 - $88.8 $1,529 - $1,864	21 Added 0.71%	2,998 $226,000
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $7,968 - $9,354	-112 Reduced 3.63%	2,977 $213,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $222,747 - $264,016	3,089	3,089 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rb Capital Management, LLC with notifications on news.